Found: 25
Select item for more details and to access through your institution.
SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-0114-1
- By:
- Publication type:
- Article
The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.
- Published in:
- Nature Communications, 2016, v. 7, n. 11, p. 13479, doi. 10.1038/ncomms13479
- By:
- Publication type:
- Article
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.
- Published in:
- Nature Communications, 2013, v. 4, n. 6, p. 2019, doi. 10.1038/ncomms3019
- By:
- Publication type:
- Article
New Treatment Strategies for Alcohol-Induced Heart Damage.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1651, doi. 10.3390/ijms17101651
- By:
- Publication type:
- Article
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12964-020-00640-8
- By:
- Publication type:
- Article
PO4-2DECREASED MYOCARDIAL TITIN EXPRESSION IN CHRONIC ALCOHOLIC CARDIOMYOPATHY.
- Published in:
- Alcohol & Alcoholism. Supplement, 2017, v. 52, p. i31, doi. 10.1093/alcalc/agx074.46
- By:
- Publication type:
- Article
Fibroblast Growth Factor-21 and the Beneficial Effects of Long-Chain n-3 Polyunsaturated Fatty Acids.
- Published in:
- Lipids, 2014, v. 49, n. 11, p. 1081, doi. 10.1007/s11745-014-3948-x
- By:
- Publication type:
- Article
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy.
- Published in:
- Journal of Pathology, 2023, v. 261, n. 3, p. 335, doi. 10.1002/path.6193
- By:
- Publication type:
- Article
The protective effect of fibroblast growth factor‐21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
- Published in:
- Journal of Pathology, 2021, v. 253, n. 2, p. 198, doi. 10.1002/path.5573
- By:
- Publication type:
- Article
Fibroblast growth factor‐21 protects against fibrosis in hypertensive heart disease.
- Published in:
- Journal of Pathology, 2019, v. 248, n. 1, p. 30, doi. 10.1002/path.5226
- By:
- Publication type:
- Article
Autophagy is Involved in Cardiac Remodeling in Response to Environmental Temperature Change.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.864427
- By:
- Publication type:
- Article
SIRT1 regulates hepatic vldlr levels.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01666-y
- By:
- Publication type:
- Article
FGF21 and cardiac physiopathology.
- Published in:
- Frontiers in Endocrinology, 2015, p. 1, doi. 10.3389/fendo.2015.00133
- By:
- Publication type:
- Article
Fatty acids and cardiac disease: fuel carrying a message.
- Published in:
- Acta Physiologica, 2014, v. 211, n. 3, p. 476, doi. 10.1111/apha.12308
- By:
- Publication type:
- Article
Peroxisome proliferator-activated receptors and inflammation: take it to heart.
- Published in:
- Acta Physiologica, 2007, v. 191, n. 3, p. 171, doi. 10.1111/j.1748-1716.2007.01752.x
- By:
- Publication type:
- Article
P120Role of fibroblast growth factor-21 in alcoholic cardiomyopathy.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
P119Cardiac remodeling in response to cold and deacclimation: role of autophagy.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Fgf21 is required for cardiac remodeling in pregnancy.
- Published in:
- Cardiovascular Research, 2017, v. 113, n. 13, p. 1574, doi. 10.1093/cvr/cvx088
- By:
- Publication type:
- Article
Fibroblast growth factor 21 protects the heart from oxidative stress.
- Published in:
- Cardiovascular Research, 2015, v. 106, n. 1, p. 19, doi. 10.1093/cvr/cvu263
- By:
- Publication type:
- Article
P612 Involvement of the cardiomyokine FGF21 in protection against oxidative stress damage in the heart.
- Published in:
- Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S110, doi. 10.1093/cvr/cvu098.41
- By:
- Publication type:
- Article
P754 Involvement of the transcription factor C/EBPbeta in pregnancy-induced cardiac hypertrophy.
- Published in:
- Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S138, doi. 10.1093/cvr/cvu098.173
- By:
- Publication type:
- Article
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
- Published in:
- Cardiovascular Research, 2011, v. 90, n. 2, p. 276, doi. 10.1093/cvr/cvq376
- By:
- Publication type:
- Article
Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes
- Published in:
- Cardiovascular Research, 2005, v. 65, n. 4, p. 832, doi. 10.1016/j.cardiores.2004.11.011
- By:
- Publication type:
- Article
Expression of Adenine Nucleotide Translocase (ANT) Isoform Genes Is Controlled by PGC-1α Through Different Transcription Factors.
- Published in:
- Journal of Cellular Physiology, 2014, v. 229, n. 12, p. 2126, doi. 10.1002/jcp.24671
- By:
- Publication type:
- Article
FGF15/FGF19 is involved in the development of cardiac hypertrophy.
- Published in:
- Cardiovascular Research, 2022, v. 118, p. 1, doi. 10.1093/cvr/cvac066.096
- By:
- Publication type:
- Article